Phenotypes of COPD in Central and Eastern Europe

NCT02119494 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3504

Last updated 2016-04-05

No results posted yet for this study

Summary

The purpose of this study is to assess the representation of COPD patients in terms of categories and phenotypes of the disease in selected countries in Central and Eastern Europe (CEE). The results of The POPE study will allow for evaluation of the differences in clinical approaches and treatment practices. The following countries are represented in The POPE study: Czech Republic, Slovakia, Austria, Poland, Hungary, Russia, Croatia, Serbia, Slovenia, Estonia, Latvia and Bulgaria.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Arschang Valipour, Assoc. Prof., MD, PhD · Vienna Hospital Association

  • Vladimir Koblizek, MD, Ph.D · University Hospital Hradec Kralove

  • Ruzena Tkacova, Prof., MD, PhD · Pavol Jozef Šafárik University in Košice

  • Neven Tudoric, Prof., MD, Ph.D · University of Zagreb, Clinical Hospital Dubrava

  • Kyrill Zykov, MD, PhD · Moscow State University of Medicine and Dentistry

  • Attila Somfay, Prof., MD, PhD · University of Szeged, Faculty of Medicine, Dept. of Pulmonology

  • Adam Barczyk, MD, PhD · Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny

  • Marc Miravitlles, Prof., MD, PhD · Hospital Universitari Vall d'hebron Barcelona, Spain

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Austria
  • Bulgaria
  • Croatia
  • Czechia
  • Hungary
  • Latvia
  • Poland
  • Russia
  • Serbia
  • Slovakia
  • Slovenia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02119494 on ClinicalTrials.gov